Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Paraneoplastic syndrome
ADR ID BADD_A08424
ADR Hierarchy
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.32      Neoplasm related morbidities
16.32.01      Paraneoplastic syndromes NEC
16.32.01.009      Paraneoplastic syndrome
Description In patients with neoplastic diseases a wide variety of clinical pictures which are indirect and usually remote effects produced by tumor cell metabolites or other products. [MeSH]
MedDRA Code 10059420
MeSH ID D010257
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Paraneoplastic syndromes | Paraneoplastic syndrome | Paraneoplastic Syndromes | Paraneoplastic Syndrome | Syndrome, Paraneoplastic | Syndromes, Paraneoplastic
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00285Bosentan0.000120%
BADD_D00349Capecitabine0.000112%
BADD_D00800Erlotinib0.000112%
BADD_D01119Ibrutinib0.000112%
BADD_D01418Methotrexate0.000114%
BADD_D01629Osimertinib0.000112%
BADD_D01831Prednisolone0.000035%
BADD_D02392Zoledronic acid--
The 1th Page    1    Total 1 Pages